Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (881-890 of 910) with videos related to

Pageof 91
Sort By:
Nature Genetics|August 13, 2002
Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathyJohane Robitaille, Marcia L E MacDonald, Ajamete Kaykas, et al.
Genome Research|April 25, 2015
Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicityMartin Stroedicke, Yacine Bounab, Nadine Strempel, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
Nature Genetics|December 3, 2003
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosisGeorge Papanikolaou, Mark E Samuels, Erwin H Ludwig, et al.
Human Molecular Genetics|January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin allelesAmber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Nature Neuroscience|May 5, 2015
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington diseaseKristina Bečanović, Anne Nørremølle, Scott J Neal, et al.
Molecular and Cellular Probes|August 29, 2003
Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory elementC F Hoogendijk, C L Scholtz, S M Pimstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 responseBarak Rotblat, Amber L Southwell, Dagmar E Ehrnhoefer, et al.
American Journal of Human Genetics|July 1, 1996
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeatsD C Rubinsztein, J Leggo, R Coles, et al.
American Journal of Human Genetics|April 3, 2004
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic IsolatesRonald G Lafreniere, Marcia L E MacDonald, Marie-Pierre Dube, et al.
Pageof 91

Showing results (881-890 of 910) with videos related to

Sort By:
Pageof 91
Nature Genetics|August 13, 2002
Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathyJohane Robitaille, Marcia L E MacDonald, Ajamete Kaykas, et al.
Genome Research|April 25, 2015
Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicityMartin Stroedicke, Yacine Bounab, Nadine Strempel, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
Nature Genetics|December 3, 2003
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosisGeorge Papanikolaou, Mark E Samuels, Erwin H Ludwig, et al.
Human Molecular Genetics|January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin allelesAmber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Nature Neuroscience|May 5, 2015
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington diseaseKristina Bečanović, Anne Nørremølle, Scott J Neal, et al.
Molecular and Cellular Probes|August 29, 2003
Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory elementC F Hoogendijk, C L Scholtz, S M Pimstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 responseBarak Rotblat, Amber L Southwell, Dagmar E Ehrnhoefer, et al.
American Journal of Human Genetics|July 1, 1996
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeatsD C Rubinsztein, J Leggo, R Coles, et al.
American Journal of Human Genetics|April 3, 2004
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic IsolatesRonald G Lafreniere, Marcia L E MacDonald, Marie-Pierre Dube, et al.
Pageof 91